On the other hand, although intravitreal anti-VEGF injections are the standard treatment for wet AMD, frequent injections can result in adverse reactions such as glaucoma, uveitis, and cataracts, as well as poor patient compliance. This evidence concerns the gene VEGFA and wet macular degeneration.